These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19704370)

  • 1. Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience.
    Shilkrut M; Bar-Deroma R; Bar-Sela G; Berniger A; Kuten A
    Am J Clin Oncol; 2010 Feb; 33(1):79-82. PubMed ID: 19704370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
    Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
    J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
    Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
    J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
    Loh KC; Fitzgerald PA; Matthay KK; Yeo PP; Price DC
    J Endocrinol Invest; 1997 Dec; 20(11):648-58. PubMed ID: 9492103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
    Gonias S; Goldsby R; Matthay KK; Hawkins R; Price D; Huberty J; Damon L; Linker C; Sznewajs A; Shiboski S; Fitzgerald P
    J Clin Oncol; 2009 Sep; 27(25):4162-8. PubMed ID: 19636009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
    Colombo L; Lomuscio G; Vignati A; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG.
    Thorpe MP; Kane A; Zhu J; Morse MA; Wong T; Borges-Neto S
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e494-501. PubMed ID: 31614368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre.
    Rutherford MA; Rankin AJ; Yates TM; Mark PB; Perry CG; Reed NS; Freel EM
    QJM; 2015 May; 108(5):361-8. PubMed ID: 25267727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.
    Gedik GK; Hoefnagel CA; Bais E; Olmos RA
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):725-33. PubMed ID: 18071700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study.
    Kotecka-Blicharz A; Hasse-Lazar K; Handkiewicz-Junak D; Gawlik T; Pawlaczek A; Oczko-Wojciechowska M; Michalik B; Szpak-Ulczok S; Krajewska J; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2018; 69(3):246-251. PubMed ID: 29645065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete hormonal and metabolic response after iodine-131 metaiodobenzylguanidine treatment in a patient diagnosed of malignant pheochromocytoma].
    García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Rodríguez Pelayo E; Mendoza Paulini A; Ortega Valle A; Penín González J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):390-3. PubMed ID: 23562188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.